Cargando…

Knockdown of the DJ-1 (PARK7) gene sensitizes pancreatic cancer to erlotinib inhibition

The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib, in combination with gemcitabine, has been shown to be a promising therapy in the treatment of pancreatic cancer. Our previous study showed that DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activat...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xiangyi, Sun, Yunwei, Fan, Rong, Sun, Jing, Zou, Douwu, Yuan, Yaozong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878983/ https://www.ncbi.nlm.nih.gov/pubmed/33614917 http://dx.doi.org/10.1016/j.omto.2021.01.013

Ejemplares similares

The Tale of DJ-1 (PARK7): A Swiss Army Knife in Biomedical and Psychological Research
por: Sun, Mo E., et al.
Publicado: (2023)

Differential effect of DJ-1/PARK7 on development of natural and induced regulatory T cells
por: Singh, Yogesh, et al.
Publicado: (2015)

Maternal PARK7 (DJ-1) levels and the preterm premature rupture of membranes: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases
por: Pap, Domonkos, et al.
Publicado: (2022)

Protective function of DJ-1/PARK7 in lipopolysaccharide and ventilator-induced acute lung injury
por: Amatullah, Hajera, et al.
Publicado: (2020)

PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
por: Lind-Holm Mogensen, Frida, et al.
Publicado: (2023)

DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs)
por: Singh, Yogesh, et al.
Publicado: (2020)

6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway
por: Urano, Yasuomi, et al.
Publicado: (2018)

Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression
por: Jin, Wook
Publicado: (2020)

A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma
por: Ben, Qiwen, et al.
Publicado: (2020)

Mitochondrial LonP1 protease is implicated in the degradation of unstable Parkinson's disease-associated DJ-1/PARK 7 missense mutants
por: Sánchez-Lanzas, Raúl, et al.
Publicado: (2021)

A model for predicting degree of malignancy in patients with intraductal papillary mucinous neoplasm
por: He, Xiangyi, et al.
Publicado: (2023)

Life-time expression of the proteins peroxiredoxin, beta-synuclein, PARK7/DJ-1, and stathmin in the primary visual and primary somatosensory cortices in rats
por: Böhm, Michael R. R., et al.
Publicado: (2015)

The association between increased maternal PARK7 (DJ-1) levels and the occurrence of preterm premature rupture of membranes - A randomized prospective study
por: Turhan, Uğur, et al.
Publicado: (2021)

Role of erlotinib in the management of pancreatic cancer
por: Starling, Naureen, et al.
Publicado: (2006)

Erlotinib in the treatment of advanced pancreatic cancer
por: Kelley, Robin K, et al.
Publicado: (2008)

Reintroduction of DJ-1 in Müller Cells Inhibits Retinal Degeneration in the DJ-1 Deficient Retina
por: Gharbi, Naouel, et al.
Publicado: (2021)

Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway
por: Chen, Liwen, et al.
Publicado: (2018)

Oxidative Neurodegeneration Is Prevented by UCP0045037, an Allosteric Modulator for the Reduced Form of DJ-1, a Wild-Type of Familial Parkinson’s Disease-Linked PARK7
por: Yamane, Koichiro, et al.
Publicado: (2009)

Mice With a Combined Deficiency of Superoxide Dismutase 1 (Sod1), DJ-1 (Park7), and Parkin (Prkn) Develop Spontaneous Retinal Degeneration With Aging
por: Zhu, Yuanfei, et al.
Publicado: (2019)

PI3K inhibition sensitizes EGFR wild-type NSCLC cell lines to erlotinib chemotherapy
por: Zhou, Xin, et al.
Publicado: (2021)

BAG5 Interacts with DJ-1 and Inhibits the Neuroprotective Effects of DJ-1 to Combat Mitochondrial Oxidative Damage
por: Qin, Li-xia, et al.
Publicado: (2017)

Knockdown of CLAUDIN-6 Inhibited Apoptosis and Induced Proliferation of Bovine Cumulus Cells
por: Wang, Wanjie, et al.
Publicado: (2022)

Metabolic Glycoengineering Sensitizes Drug-Resistant Pancreatic Cancer Cells to Tyrosine Kinase Inhibitors Erlotinib and Gefitinib
por: Mathew, Mohit P., et al.
Publicado: (2015)

Inhibitors of lysosomal function or serum starvation in control or LAMP2 deficient cells do not modify the cellular levels of Parkinson disease-associated DJ-1/PARK 7 protein
por: Sánchez-Lanzas, Raúl, et al.
Publicado: (2018)

The role of DJ-1 in anti-apoptosis
por: Ren, Haigang, et al.
Publicado: (2012)

Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation
por: Tang, Yong, et al.
Publicado: (2012)

The Mobile DJ Handbook
por: Zemon, Stacy
Publicado: (2013)

DJ Ethics and Law
Publicado: (2022)

Transduced Tat-DJ-1 protein inhibits cytokines-induced pancreatic RINm5F cell death
por: Jo, Hyo Sang, et al.
Publicado: (2016)

Ron Knockdown and Ron Monoclonal Antibody IMC-RON8 Sensitize Pancreatic Cancer to Histone Deacetylase Inhibitors (HDACi)
por: Zou, Yi, et al.
Publicado: (2013)

Knockdown of Snail Sensitizes Pancreatic Cancer Cells to Chemotherapeutic Agents and Irradiation
por: Zhang, Kejun, et al.
Publicado: (2010)

Correction: Inhibitors of lysosomal function or serum starvation in control or LAMP2 deficient cells do not modify the cellular levels of Parkinson disease-associated DJ-1/PARK 7 protein
por: Sánchez-Lanzas, Raúl, et al.
Publicado: (2020)

Transcriptional Activation of the Cholecystokinin Gene by DJ-1 through Interaction of DJ-1 with RREB1 and the Effect of DJ-1 on the Cholecystokinin Level in Mice
por: Yamane, Takuya, et al.
Publicado: (2013)

Serum metabolomics differentiating pancreatic cancer from new-onset diabetes
por: He, Xiangyi, et al.
Publicado: (2017)

Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer
por: Cardin, Dana B, et al.
Publicado: (2014)

Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET
por: Abourbeh, Galith, et al.
Publicado: (2015)

Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation
por: Tang, Yong, et al.
Publicado: (2013)

Knockdown of B7H6 inhibits tumor progression in triple-negative breast cancer
por: Zhang, Bing, et al.
Publicado: (2018)

The DJ Sales and Marketing Handbook
por: Zemon, Stacy
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lrcg7jcafgn5huff4nn459qf45